Sotera Health Company $SHC Shares Acquired by Darsana Capital Partners LP

Darsana Capital Partners LP boosted its holdings in Sotera Health Company (NASDAQ:SHC) by 3.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,000,000 shares of the company’s stock after purchasing an additional 1,000,000 shares during the period. Sotera Health comprises about 2.2% of Darsana Capital Partners LP’s portfolio, making the stock its 4th largest holding. Darsana Capital Partners LP owned 9.46% of Sotera Health worth $479,250,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Sotera Health during the 2nd quarter worth about $428,635,000. Sculptor Capital LP bought a new position in shares of Sotera Health in the 2nd quarter valued at about $426,000,000. Sachem Head Capital Management LP increased its position in shares of Sotera Health by 47.2% in the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after acquiring an additional 3,735,000 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of Sotera Health by 35.3% in the first quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock valued at $131,413,000 after acquiring an additional 2,390,132 shares during the last quarter. Finally, Jupiter Topco LLC bought a new stake in Sotera Health during the second quarter worth about $149,137,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Trading Down 1.4%

Sotera Health stock opened at $18.33 on Thursday. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The stock has a market capitalization of $5.23 billion, a P/E ratio of 32.16 and a beta of 1.77. The stock has a 50-day simple moving average of $18.41 and a 200 day simple moving average of $16.49.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same quarter in the prior year, the company earned $0.20 earnings per share. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Analysts expect that Sotera Health Company will post 0.86 earnings per share for the current year.

Insider Buying and Selling

In other Sotera Health news, Chairman Michael Petras, Jr. sold 850,000 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. This trade represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Michael Rutz sold 150,000 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,294,515 shares of company stock worth $23,999,528 over the last three months. 15.36% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. JPMorgan Chase & Co. increased their price target on Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price objective on the stock. UBS Group set a $19.00 price objective on Sotera Health in a report on Wednesday, June 24th. Weiss Ratings raised shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, Piper Sandler restated an “overweight” rating and set a $25.00 target price on shares of Sotera Health in a report on Tuesday. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and a consensus price target of $21.50.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.